---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-228064"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2022-08-24T23:59:59+00:00"
generated_at: "2026-06-23T21:52:14.129282+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences voluntarily recalls all CereLink ICP monitors; cuts guidance by $9M

## Summary
- Voluntary global removal of all CereLink intracranial pressure monitors due to out-of-range readings from electrical interference.
- Records $9M returns provision in Q3 2022; Q3 revenue guidance lowered to $374-382M from $383-391M.
- Full-year revenue guidance reduced to $1,548-1,566M from $1,557-1,575M; adjusted EPS lowered to $3.12-3.20 from $3.21-3.29.
- Low incidence rate at limited sites; investigation ongoing; plans to resume shipments after resolution.

## SEC filing metadata
- accession: 0001193125-22-228064
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2022-08-24T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000119312522228064/0001193125-22-228064-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000119312522228064/d366857d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-228064
- JSON: https://secwatch.observer/filing/0001193125-22-228064.json
- Plain text: https://secwatch.observer/filing/0001193125-22-228064.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.